Navigation Links
Worcester Polytechnic Institute Receives NIH Grant to Study Components of a Potentially Potent and Cost-Effective Malaria Treatment
Date:7/15/2014

pal therapeutic compound in the plant, is extracted, purified, and combined with other drugs to make ACT. Weathers’s team takes a different approach, using dried whole leaves from Artemisia annua as a medication.

In previous work Weathers and her colleagues have shown that mice fed powered dried leaves had 40 times more artemisinin in their blood stream than mice fed pure artemisinin. Furthermore, the whole-plant therapy was five times more effective in clearing the disease-causing parasite from the mice. In addition to delivering more artemisinin to the bloodstream, the effectiveness of the whole plant treatment may be due to the presence of other potentially therapeutic compounds in the leaves.

In the new study, Weathers will use a laboratory model of the human digestive system to discover which compounds in the leaves move through the intestinal wall. She will focus on several compounds, including flavonoids and terpenes, which have exhibited antimalarial effects of their own and which may also help artemisinin move through the intestinal wall and into the bloodstream where it can attack the malaria parasite.

Flavonoids are widely distributed in plants and have various functions, including giving blossoms color. They are also believed to work synergistically with artemisinin to kill the malaria parasite. Terpenes are among the essential oils that play a role in the plant’s defense system. Secreted terpenes have anti-microbial properties and deter some leaf-eating predators.

In a series of experiments over the next three years, the Weathers lab will use a cell culture model to study how the flavonoids and terpenes move through a layer of cultured human intestinal wall cells. They will also test the flavonoids and terpenes in combination with artemisinin to see how they affect the movement of artemisinin across the cell layer.

“Because these other compounds in the plant have some therapeutic activity, using the whole plant be
'/>"/>

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Averica Discovery Services and Worcester Polytechnic Institute Establish Research Collaboration
2. Worcester Polytechnic Institute’s Tanja Dominko Named Slovenian Ambassador of Science for 2013
3. Masaryk Memorial Cancer Institute Reduces Losses and Administrative Overhead With Ekahau RTLS
4. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
5. The Pharmabiotic Research Institute (PRI) is Preparing to Publish its First Works on the Therapeutic and Medicinal Potential of Probiotics
6. Michael A. Marletta Takes Office as New President of Scripps Research Institute
7. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
8. QIAGEN and Max Planck Institute for Infection Biology Collaborate to Develop Assay for Active TB Risk in Individuals With Latent Infection
9. DFH Pharma to Collaborate With National Cancer Institute to Develop Second-Generation HIV Maturation Inhibitor Drugs
10. Niels Bohr Institute gets top researcher from Harvard
11. Van Andel Research Institute Study Provides New Details of Fundamental Cellular Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 23, 2014 “Preparative & Process ... Flash), Consumables (Columns, Solvents, Buffers, Valves, Guages, Seals), ... Agriculture) - Forecasts to 2019” provides a detailed ... current market trends, and strategies impacting the preparative ... and forecasts of the revenue and share analysis. ...
(Date:12/24/2014)... Earlier this year in a June ... of the Adult Stem Cell Technology Center, LLC ( ... under appreciated unique property of adult tissue stem cells. ... Misunderstood in the Past, Important for the Future,” embodied ... He gave the address at the 4th World Congress ...
(Date:12/24/2014)... On Friday, December 19, 2014, President ... and Continuing Resolution Appropriations Act of 2015, which ... eligible to receive funding through the Congressionally Directed ... of Defense (DoD). The Hydrocephalus Association (HA), working ... is celebrating this victory for the over 1 ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 ... mercaptan such as its definition, classification, application ... product specification, manufacturing process, and product cost ... and applications. The analysis also covers upstream ... channels, industry development trend and proposals. In ...
Breaking Biology Technology:Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2
... Bio-Optronics, Inc. and flexcipio s.a. are pleased ... Bio-Optronics, Clinical Conductor Clinical Trial Management System (CTMS) ... This aligns the industry,s most comprehensive enterprise CTMS, ... with the best tools to optimize efficiency, productivity, ...
... European Trials Commencing for Injectable Biopolymer to Repair ... Symphony Medical, Inc., a developer of novel biopolymer ... patented flagship technology, Algisyl-LVR(R), was used on a ... 50-year-old male who was suffering from chronic heart ...
... BioVex Inc, a company developing next generation biologics for the ... that its OPTiM (OncoVEX Pivotal Trial in Melanoma) Phase 3 ... III and Stage IV melanoma had initiated. The study has ... United Kingdom, Germany and Australia due to open later in ...
Cached Biology Technology:Bio-Optronics Adds Innovative Electronic Data Capture (EDC) Solution to Clinical Conductor Clinical Trial Management System (CTMS), Continues to Improve Workflow and Productivity 2Symphony Medical Announces First Patient Successfully Treated With Novel Congestive Heart Failure Therapy 2Symphony Medical Announces First Patient Successfully Treated With Novel Congestive Heart Failure Therapy 3Symphony Medical Announces First Patient Successfully Treated With Novel Congestive Heart Failure Therapy 4BioVex Commences OncoVEX (GM-CSF) Phase 3 Trial in Metastatic Melanoma 2BioVex Commences OncoVEX (GM-CSF) Phase 3 Trial in Metastatic Melanoma 3BioVex Commences OncoVEX (GM-CSF) Phase 3 Trial in Metastatic Melanoma 4
(Date:12/5/2014)... 4, 2014  Tute Genomics, a leader in cloud-based ... Series A1 funding led by UK-based Eurovestech. Peak Ventures ... the investment round. "We are at a ... next-generation sequencing and seeks new approaches for the diagnosis, ... , MD MBA, and CEO of Tute Genomics. "One ...
(Date:11/21/2014)... , November 18, 2014 ... Systems Market by Systems (Video, RFID, Access Control, Intrusion ... Factories, Hotels, Banks, Government), Component Service Geography - Global ... Systems Market is projected to be around $25 Billion ... by 2020, growing at a CAGR of 8.69%. ...
(Date:11/21/2014)...   Atmel® Corporation (NASDAQ: ATML ... technology solutions, today launched the industry,s first family of ... V cc range from 1.7V to 5.5V. The ... 2 C bus communication speeds, and are available with ... ideal for consumer, industrial, computer, and medical applications. ...
Breaking Biology News(10 mins):Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4
... a virus,s tiny exterior is a store of energy ... host cell, this pent-up energy is released, propelling the ... a virus factory. For the first time, Carnegie Mellon ... associated with the expulsion of viral DNA, a pivotal ...
... have found a critical piece in the evolutionary puzzle ... centuries ago. The team, from the School of ... developed into more complex cells and found this crucial ... previously thought. Team leader and ARC Federation ...
... A new study of children in Ukraine has found ... quality of care and the relationship between children and ... Based on their findings, the researchers highlight the importance ... relationships by changing caregivers, working schedules and providing training ...
Cached Biology News:Carnegie Mellon first to measure energy released from a virus during infection 2Carnegie Mellon first to measure energy released from a virus during infection 3An answer to another of life's big questions 2For HIV-infected children, quality of caregiver relationship is crucial 2